LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM) recently published the White Paper: Innovations in Pain Management discussing the epidemic of pain, the dangers of commonly prescribed pain medications and the benefits of Theramine as a clinically effective alternative to opioids and nonsteroidal anti-inflammatory (NSAID) drugs for the management of back pain and inflammation.
According to Consumer Reports, the overuse of opioid pain medications has reached epidemic proportions in the United States, and poses a significant public health problem. Roughly 45 people a day and more than 16,600 people a year, die from overdoses of these drugs, including methadone, morphine, and oxycodone (OxyContin) and hydrocodone combined with acetaminophen (Lortab and Vicodin). On September 30, 2014, the American Academy of Neurology published their new position regarding opioids, stating that the risks of opioids outweigh the benefits for headache, low back pain and other chronic conditions.
Help employers find you! Check out all the jobs and post your resume.
